By Nigam Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning
By Nigam Arora To gain an edge, this is what you need to know today. AI Cap Ex Please click here for a chart of Google stock (GOOG). Note the following: The Morning Capsule is about the big picture, not an individual stock. The chart of GOOG stock is being used
By Nigam Arora To gain an edge, this is what you need to know today. AI Disruption Fears (Fear Overtakes Greed) Please click here for a chart of Salesforce stock (CRM). Note the following: The Morning Capsule is about the big picture, not an individual stock. The chart of CRM stock
By Nigam Arora To gain an edge, this is what you need to know today. Problem For Nvidia Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: The stock market approached the upper band of zone
By Nigam Arora Editor’s note: This post was published yesterday in The Arora Report paid feeds. 217th Buyout Novo Nordisk (NVO) and Pfizer (PFE) have been in a bidding war over biotech Metsera (MTSR). Pfizer prevailed, making Metsera the 217th Arora portfolio company to be bought out. Late Friday evening, MTSR stock
By Nigam Arora NVO, the maker of weight loss drug Wegovy, is buying AKRO. The deal is for $60 per share. The deal consists of $54 per share in cash to be paid on closing and $6 per share in cash upon U.S. regulatory approval of efruxifermin drug cirrhosis. What To
By Nigam Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning
By Nigam Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning
By Nigam Arora To gain an edge, this is what you need to know today. Deploy Cash And Reduce Hedges Please see the Protection Band And What To Do Now section below. The change is triggered by the prospect of China tariffs being reduced to 10%. Great Deal For China Please
By Nigam Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning